What is likely to be the future burden of MAC and NTM lung disease as our populations ages?

What is likely to be the future burden of MAC and NTM lung disease as our populations ages?

What is likely to be the future burden of MAC and NTM lung disease as our populations ages?


Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | NTM-Pulmonary Infection Intelligence Zone

Presenter

Mehdi Mirsaeidi, MD, MPH

Mehdi Mirsaeidi, MD, MPH

Director of University of Miami and VA Sarcoidosis Programs Co-Director UM NTM Program IRB Vice-Chairman, Miami VA Healthcare System Assistant Professor of Department of Medicine Assistant Professor of Clinical Public Health Sciences Division of Pulmonary